See other Neocon Nuttery Articles
Title: Medical Director: Swine Flu Was “Cultured In A Laboratory”
Source:
INFOWARS
URL Source: http://www.infowars.com/medical-dir ... -was-cultured-in-a-laboratory/
Published: Apr 25, 2009
Author: Paul Joseph Watson
Post Date: 2009-04-26 21:41:14 by Rotara
Ping List: *Obama Reality Check* Subscribe to *Obama Reality Check*
Keywords: None
Views: 702
Comments: 28
Editor’s note: On Friday, NPR reported that the deadly swine flu “combines genetic material from pigs, birds and humans in a way researchers have not seen before,” thus leading us to suspect it was cooked up in a lab. Swine flu panic is spreading in Mexico and soldiers are patrolling the streets after it was confirmed that human to human transmission is occurring and that the virus is a brand new strain which is seemingly affecting young, healthy people the worst. Questions about the source of the outbreak are also being asked after a public health official said that the virus was “cultured in a laboratory”. “This strain of swine influenza that’s been cultured in a laboratoryis something that’s not been seen anywhere actually in the United States and the world, so this is actually a new strain of influenza that’s been identified,” said Dr. John Carlo, Dallas Co. Medical Director (video clip here). Was this a slip-up or an admission that this new super-strain of swine influenza was deliberately cultured in a laboratory and released? Alarming reports are now filtering in about people catching the illness who have had no contact with pigs whatsoever. These include a man and his daughter in San Diego County, a 41-year-old woman in Imperial County and two teenagers in San Antonio, Texas. In fact, in all U.S. cases, the victims had no contact with any pigs. Dr. Wilma Wooten, San Diego County’s public health officer, told KPBS “We have had person-to-person spread with the father and the daughter,” says Wooten, “And also with the two teenagers in Texas, they were in the same school. So that also indicates person-to-person transfer.” “Dr. Wooten says it’s unclear how people were exposed to swine flu. She says none of the patients have had any contact with pigs,” according to the report. Although the situation in the U.S. looks under control, panic is spreading in Mexico, where 800 cases of pneumonia in the capital alone are suspected to be related to the swine flu and the virus has hit young and healthy people, which is very rare with an flu outbreak. Despite the danger of a pandemic, the U.S. border with Mexico remains open. “Mexico has shut schools and museums and canceled hundreds of public events in its sprawling, overcrowded capital of 20 million people to try to prevent further infections,” reports Reuters. “My level of concern is significant,” said Dr. Martin Fenstersheib, the health officer for Santa Clara County. “We have a novel virus, a brand-new strain that’s spreading human to human, and we are also seeing a virulent strain in Mexico that seems to be related. We certainly have concerns for this escalating.” The WHO insists that the outbreak has “pandemic potential” and has been stockpiling supplies of Tamiflu, known generically as oseltamivir, a pill that can both treat flu and prevent infection, according to officials. As we previously highlighted, those that have a stake in the Tamiflu vaccine include top globalists and BIlderberg members like George Shultz, Lodewijk J.R. de Vink and former Secretary of Defense Donald Rumsfeld. Indeed, Rumsfeld himself played a key role in hyping an outbreak of swine flu back in the 1976 when he urged the entire country to get vaccinated. Many batches of the vaccine were contaminated, resulting in hundreds of sick people and 52 fatalities. The fact that the properties of the strain are completely new, that the virus is spreading from people to people, and that the young and healthy are being hit worst, has disturbing parallels to the deadly 1918 pandemic that killed millions. It is unclear as to why, if the virus is a brand new strain, that public health officials are so confident programs of mass vaccination, which are already being prepared, would necessarily be effective. It certainly wouldn’t be the first time that deadly flu viruses have been concocted in labs and then dispatched with the intention of creating a pandemic. When the story first broke last month, Czech newspapers questioned if the shocking discovery of vaccines contaminated with the deadly avian flu virus which were distributed to 18 countries by the American company Baxter were part of a conspiracy to provoke a pandemic. Since the probability of mixing a live virus biological weapon with vaccine material by accident is virtually impossible, this leaves no other explanation than that the contamination was a deliberate attempt to weaponize the H5N1 virus to its most potent extreme and distribute it via conventional flu vaccines to the population who would then infect others to a devastating degree as the disease went airborne. However, this is not the first time that vaccine companies have been caught distributing vaccines contaminated with deadly viruses. In 2006 it was revealed that Bayer Corporation had discovered that their injection drug, which was used by hemophiliacs, was contaminated with the HIV virus. Internal documents prove that after they positively knew that the drug was contaminated, they took it off the U.S. market only to dump it on the European, Asian and Latin American markets, knowingly exposing thousands, most of them children, to the live HIV virus. Government officials in France went to prison for allowing the drug to be distributed. The documents show that the FDA colluded with Bayer to cover-up the scandal and allowed the deadly drug to be distributed globally. No Bayer executives ever faced arrest or prosecution in the United States. In the UK, a 2007 outbreak of foot and mouth disease that put Britain on high alert has been originated from a government laboratory which is shared with an American pharmaceutical company, mirroring the deadly outbreak of 2001, which was also deliberately released. As we reported yesterday, last time there was a significant outbreak of a new form of swine flu in the U.S. it originated at the army base at Fort Dix, New Jersey.
Subscribe to *Obama Reality Check*
Post Comment Private Reply Ignore Thread
Top • Page Up • Full Thread • Page Down • Bottom/Latest
Begin Trace Mode for Comment # 20.
#3. To: Rotara (#0)
Donald Rumsfeld makes $5m killing on bird flu drug (The Independent)
za.today.reuters.com/news...S-USA-STOCKS-20051008.XML US stocks rise slightly, Gilead lifts Nasdaq Sat Oct 8, 2005 10:27 AM GMT11 Heightened concern about the possible threat of avian influenza drove up shares of Gilead, whose drug Tamiflu it co-developed with Roche is cited as a possible tool to combat the disease. Gilead, up 4.8 percent at $47.69, provided the greatest support to the Nasdaq. ------------------- 66.102.7.104/search?q=cac...d+sciences+rumsfeld&hl=en DONALD H. RUMSFELD Secretary of Defense Until being sworn in as the 21st Secretary of Defense, Mr. Rumsfeld served as Chairman of the Board of Gilead Sciences, Inc., a pharmaceutical company. --------------------------- Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from... 66.102.7.104/search?q=cac...d+sciences+rumsfeld&hl=en Donald H. Rumsfeld Named Chairman of Gilead Sciences Foster City, CA, January 3, 1997 - Gilead Sciences Inc. (Nasdaq: GILD) today announced that board member Donald H. Rumsfeld will assume the position of Chairman, effective immediately. Mr. Rumsfeld succeeds Michael L. Riordan, M.D., who founded Gilead in 1987 and has served as Chairman since 1993. Dr. Riordan will continue to serve as a director on the board. "Gilead is fortunate to have had Don Rumsfeld as a stalwart board member since the company's earliest days, and we are very pleased that he has accepted the Chairmanship," Dr. Riordan said. "He has played an important role in helping to build and steer the company. His broad experience in leadership positions in both industry and government will serve us well as Gilead continues to build its commercial presence." "In my years with Gilead, I have witnessed the evolution of one of the industry's premier biotechnology companies," Mr. Rumsfeld said. "Michael Riordan's founding vision and enormous accomplishments are evident in the VISTIDE® product approval, deep pipeline and talented team that will continue to move Gilead to develop novel treatments for viral diseases." Mr. Rumsfeld, who joined Gilead as a director in 1988, is currently in private business and is distinguished for his accomplishments in both industry and government. Mr. Rumsfeld served as chief executive officer of G.D. Searle, a worldwide pharmaceutical company, from 1977 to 1985. During this time, his stewardship of Searle earned him awards as the Outstanding Chief Executive Officer in the pharmaceutical industry in 1980 and 1981. He also served as chairman and chief executive of General Instrument Corporation, a diversified electronics company and world leader in broadband and all digital high definition television technology. A graduate of Princeton University, Mr. Rumsfeld has served in numerous positions of public service, including four terms in the U.S. Congress, U.S. Ambassador to NATO, White House Chief of Staff and as the 13th Secretary of Defense. In 1977, Mr. Rumsfeld was awarded the nation's highest civilian award, the Presidential Medal of Freedom. In addition to Gilead, Mr. Rumsfeld presently serves as an advisor to several companies and as a member of the board of directors of ABB AB; Gulfstream Aerospace Corp.; Kellogg; Metricom, Inc.; Sears, Roebuck and Co. and Tribune Company. Mr. Rumsfeld's current civic activities include service on the board of trustees of the Eisenhower Exchange Fellowship, Freedom House and the RAND Corporation. Dr. Riordan will continue to assist the company with strategic direction through his involvement on the board of directors. Since founding the company in 1987, Riordan has overseen Gilead's evolution to a leading biotechnology company with its first approved product and a diversified pipeline of antiviral therapies. "Michael Riordan's vision and leadership have guided Gilead from a start-up to a commercial company, and we are pleased to rely on his continued counsel as an active board member," John C. Martin, Ph.D., President and Chief Executive Officer of Gilead said. "Over the past several years, I have enjoyed working with Don Rumsfeld as an active director and look forward to his new role as Chairman as we continue to build the Gilead business." Gilead Sciences is a leader in the discovery and development of a new class of human therapeutics based on nucleotides, the building blocks of DNA and RNA. In 1996, Gilead's first product, VISTIDE (cidofovir injection), was cleared by the U.S. Food & Drug Administration for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. Gilead has other nucleotide product candidates in human testing for the potential treatment of viral diseases caused by CMV, human immunodeficiency virus (HIV), hepatitis B virus, herpes simplex virus and human papillomavirus. The Company's research and development efforts encompass three interrelated programs: small molecule antivirals, cardiovascular therapeutics and genetic code blockers for cancer and other diseases. Gilead's expertise in each of these areas has also resulted in the discovery and development of non-nucleotide product candidates, including neuraminidase inhibitors for the potential treatment and prevention of viral influenza and protease inhibitors for the potential treatment of HIV. ---------------- 66.102.7.104/search?q=cac...om/+gilead+sciences&hl=en Gilead Sciences Approximately 1,600 employees in North America, Europe and Australia contribute to the Gilead mission of advancing patient care by developing ground-breaking therapeutics to treat life-threatening infectious diseases. ----------- Gilead Sciences is committed to increasing global access to Truvada and Viread for people living with HIV. The Gilead Access Program helps address this need in the developing world. www.gileadaccess.org ------------ www.opensecrets.org/bush/cabinet/cabinet.rumsfeld.asp The Bush Administration Donald Rumsfeld DEFENSE SECRETARY (2001-present) Donald Rumsfeld has had a busy professional career. After serving as Gerald Ford’s defense secretary in 1977, he joined the private sector as the CEO of G.D. Searle, a pharmaceutical company that’s now a subsidiary of Pfizer. He was also the CEO of General Instrument, a telecommunications parts supplier that was eventually bought out by Motorola. Prior to joining President Bush's cabinet, Rumsfeld served on the boards of several companies: Gilead Sciences, a fledgling biotech company; newspaper giant Tribune Company, which owns the Chicago Tribune and Los Angeles Times; Amylin Pharmaceuticals; Swiss firm Asea Borwn Boveri; and Fortune 500 behemoths Kellogg, Sears and Allstate. As a director for Gulfstream Aerospace, his stock in the company reportedly was valued at $11 million when the company was acquired by defense contractor General Dynamics in 1999. But Rumsfeld scrupulously avoided any direct dealings with defense companies, either serving on boards or purchasing stock, a decision that helped to avoid the appearance of impropriety when he was asked to lead the Defense Department again. Feel free to distribute or cite this material, but please credit the Center for Responsive Politics. ------------- www.thanhniennews.com/healthy/?catid=8&newsid=9289 Hot News: - Last Updated: Tuesday, September 20, 2005 11:14:51 Vietnam (GMT+07) E-mail to a friend E-mail to a friend Print versionPrint version Hot News: - Last Updated: Tuesday, September 20, 2005 11:14:51 Vietnam (GMT+07) WHO won't push for generic bird flu drug World Health Organization Director General Lee Jong-wook (Source: AP.) The World Health Organization on Monday rejected suggestions that it push for a lower-cost, generic version of a patented drug to treat people with the deadly bird flu virus in poor countries. Speaking at a conference of health ministers and experts from more than 20 countries, Director-General Lee Jong-wook said WHO wouldn't pressure Swiss-based Roche Holding AG to relinquish its patent on oseltamivir. Sold under the brand name Tamiflu, it is the only treatment so far proven effective against bird flu in humans. Last month, Roche announced it would donate 3 million treatment courses of Tamiflu to a WHO-managed stockpile. "When a company is doing its part, it (pushing for a generic option) is not a good incentive, encouragement (for the company) to do more," Lee told The Associated Press. Lee was attending a five-day Western Pacific Regional meeting of the WHO that began Monday in Noumea, capital of the French South Pacific island of New Caledonia. He told the conference the issue "is not owned by WHO" and that each country must develop its own strategy to fight a potential avian influenza outbreak in humans. Many wealthy countries are stockpiling Tamiflu, but numerous poor countries in Southeast Asia — where a pandemic is considered most likely to begin — have none of the drug, or only minimal supplies. Some countries have suggested that WHO should press Roche to relinquish its patent rights to Tamiflu, clearing the way for other companies to produce cheaper, generic versions of the drug. "We are very keen to see generic versions of this anti-viral drug available, but we will not pressure Roche to do so (relinquish its patent)," said Peter Cordingley, a WHO spokesman. Roche said Monday that it was cooperating with international agencies and other companies to supply the drug. "Roche is working as a collaborative and responsible partner with governments and the World Health Organization to assist in pandemic planning, including the stockpiling of Tamiflu," Roche spokeswoman Martina Rupp said. ------
#21. To: TwentyTwelve (#20)
What exactly are you saying ?? ;-)
Top • Page Up • Full Thread • Page Down • Bottom/LatestruMSfeld bump
#6. To: lodwick (#3)
I bet that's not ALL the cs'ers 'made' !!
#20. To: Rotara (#6)
Donald Rumsfeld makes $5m killing on bird flu drug (The Independent)
Replies to Comment # 20. So what's your point ??
End Trace Mode for Comment # 20.